What a reference standard is, and what an in-house standard is not
Matching a retention time against a standard is evidence of consistency, not proof of identity. Two different species can elute at the same time on one method.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Instrumentation
A peptide has a monoisotopic mass and an average mass, they differ by several daltons at this molecular size, and a certificate that does not say which it quotes cannot be checked.
The commonest arithmetic error in this trade is not a miscalculation. It is a comparison between two figures that were never comparable: an observed monoisotopic mass set against a theoretical average mass, or the reverse. Both numbers are correct. The comparison is meaningless, and it will produce an apparent discrepancy of two to three daltons on an incretin-sized peptide — enough to look like a real finding, enough to start an argument, and entirely an artefact of convention. The Journal has seen this happen three times in correspondence and has done it once itself, which is recorded in the corrections log.
It is worth being exact about what a mass spectrometer does, because the imprecision propagates. The instrument generates ions from a sample, separates them according to the ratio of their mass to their charge, and counts them at a detector. The horizontal axis of every spectrum is mass-to-charge, conventionally written m/z and expressed in thomsons or in dimensionless units depending on the vendor’s software. Nothing is weighed. Nothing is measured against a reference mass in the sense that a balance measures against a calibration weight.
What follows from this is that every molecular weight on every certificate of analysis in this market is a calculated quantity, derived from a measured m/z by assigning a charge and subtracting the mass contribution of whatever adducted to the molecule to give it that charge — usually protons, sometimes sodium, occasionally potassium or ammonium. The assignment is normally straightforward and normally correct. It is nonetheless an assignment, and when it goes wrong it goes wrong by an integer factor, which is the kind of error that produces confident nonsense rather than a plausible discrepancy.
The practical consequence for a reader is a habit: when a mass figure appears, ask what was observed and what was inferred. A report that gives both — the m/z, the charge, and the derived neutral mass — has answered the question before it was asked.
The monoisotopic mass of a molecule is calculated using the exact mass of the most abundant stable isotope of each element: carbon-12 at exactly 12, hydrogen-1 at 1.00783, nitrogen-14 at 14.00307, oxygen-16 at 15.99491. The average mass uses the standard atomic weights, which are abundance-weighted means over the natural isotopic distribution: carbon at 12.011, nitrogen at 14.007, and so on. For a small molecule the two differ negligibly. For a peptide of four thousand daltons containing roughly one hundred and ninety carbon atoms, the difference is on the order of two and a half daltons.
Which one a laboratory should quote depends on what it measured. If the instrument resolved the isotopic envelope, the monoisotopic peak is identifiable and monoisotopic mass is the correct quantity to report. If the envelope was not resolved — which is the ordinary situation on a linear time-of-flight instrument at this molecular weight — the centroid of the unresolved cluster approximates the average mass, and that is what should be quoted.
The error is not in choosing one convention. It is in comparing across them. An observed monoisotopic value set against a theoretical average value will disagree by two to three daltons at incretin molecular weights, and the resulting apparent discrepancy has the size and shape of a real analytical finding. Any identity statement that does not name its convention is one step removed from being uncheckable.1
The trade borrowed the instrument from proteomics and not the epistemology. The word confirmed is doing the rest of the work.
For a peptide of neutral monoisotopic mass M observed as a protonated ion carrying z protons, the mass-to-charge ratio is (M + z × 1.00728) divided by z, where 1.00728 is the mass of a proton — the mass of a hydrogen atom less the mass of an electron, a distinction that matters at parts-per-million accuracy and not at all below it.
Run this for a peptide of average mass 4113.58. The singly protonated ion appears at 4114.59. The doubly protonated ion appears at 2057.80, the triply at 1372.20, the quadruply at 1029.40 and the quintuply at 823.72. All five describe the same molecule. A reader shown only the fourth of those figures, without a charge assignment, would reasonably conclude the vial contained a peptide of about a thousand daltons.
Inverting the calculation is how the neutral mass is recovered: multiply the observed m/z by the charge and subtract z proton masses. Doing this for two or three charge states from the same spectrum and finding agreement to within the instrument’s stated accuracy is the standard internal consistency check, and it is the check that catches a misassigned charge. A single m/z with a single assumed charge has no such redundancy, which is one reason electrospray with a visible charge-state envelope is more informative than a single MALDI peak even when both instruments are equally well calibrated.
| Change | Mass shift (Da) | Shift (ppm at 4000 Da) | Resolving power required |
|---|---|---|---|
| Oxidation (one O added) | +15.995 | 3999 | ~250 |
| Deamidation of Asn or Gln | +0.984 | 246 | ~4100 |
| Disulphide formation | −2.016 | 504 | ~2000 |
| Pyroglutamate formation | −18.011 | 4503 | ~220 |
| TFA adduct | +113.993 | 28498 | ~35 |
| Gln replaced by Lys | −0.036 | 9 | ~110000 |
| Leu replaced by Ile | 0.000 | 0 | not resolvable |
| L to D inversion | 0.000 | 0 | not resolvable |
| Required resolving power estimated as the parent mass divided by the mass shift, which is the minimum needed to present the two species as separate peaks; in practice a factor of two above this figure is needed for reliable quantitation of the minor species. | |||
Because carbon-13 is present at roughly 1.1% natural abundance, a peptide containing one hundred and ninety carbon atoms will exist substantially as molecules containing one, two or three carbon-13 atoms. In a spectrum this appears as a series of peaks above the monoisotopic peak, separated in mass by approximately 1.00336 daltons and distributed in intensity according to the binomial statistics of the composition.
Two things follow, and both are practically useful. First, the spacing between adjacent isotope peaks in a charge-state cluster is one over the charge: a spacing of 0.5 on the m/z axis means the ion is doubly charged, 0.333 means triply, 0.25 means quadruply. This is the simplest charge assignment available and it requires no assumptions about the sample at all. Second, the relative intensities of the isotope peaks are predictable from the elemental composition, so a cluster whose shape departs markedly from the calculated envelope is evidence that two species are overlapping.
Both observations require an instrument capable of resolving the isotope peaks at the relevant m/z, which is where resolving power stops being a specification-sheet number and becomes the thing that determines whether a spectrum can be interpreted at all. Below roughly ten thousand resolving power, a multiply charged peptide envelope collapses into a single broad hump that carries neither the spacing nor the shape information.
Deamidation of asparagine proceeds through a five-membered succinimide intermediate formed by nucleophilic attack of the following residue’s backbone nitrogen on the asparagine side-chain carbonyl. Hydrolysis of the intermediate yields aspartate or isoaspartate, in a ratio typically favouring the isoaspartate form. Glutamine deamidates by an analogous but slower route. The rate depends strongly on pH, temperature, and the identity of the residue immediately following the asparagine, with glycine and serine accelerating it markedly.2
The analytical difficulty is threefold. The mass increase is 0.984 daltons, which requires only modest resolving power to see at low molecular weight and becomes demanding as the peptide gets larger. The aspartate and isoaspartate products are exactly isobaric with one another, so distinguishing them requires either a chromatographic separation that happens to resolve them or a specific enzymatic assay. And deamidated species often elute close to the parent under reversed-phase conditions, so a fast gradient may not separate them either.
The result is a degradation product that is common, that has real consequences for biological activity, that accumulates in storage, and that a certificate produced by a unit-resolution instrument on a twelve-minute gradient is structurally unable to detect. When the Journal describes a certificate as silent on stability, this is a large part of what is meant.
Follow a mass spectrum through the market and its meaning changes at every step. A laboratory issues a report to whoever submitted the sample, stating what was observed on a named instrument on a named date. The submitter — a vendor, in most cases — extracts a figure and a verdict onto a certificate of analysis for the lot. A reseller reproduces the certificate, or a portion of it. A listing page distils the whole chain into a phrase: identity verified.
Nothing dishonest need happen at any step for the final phrase to support far more than the original report does. The instrument’s resolving power is lost at step two. The convention behind the theoretical mass is lost at step two or three. The date, the batch and the submitter’s identity survive unevenly. By the time the claim reaches a buyer it has become a property of the product rather than a record of a measurement on one vial from one lot on one day.
This is the structural reason the Journal reports identity claims by asking for the underlying laboratory report rather than the certificate. When a supplier supplies it, the claim usually holds up and often turns out to be stronger than the certificate suggested. When a supplier cannot locate it, that is itself information about how far back the documentary chain reaches, and we report that too, without inferring anything about the material.
This publication applies one rule to every identity claim it reports, and it is worth stating in isolation because it governs the rest. A mass measurement supports a statement about composition. Only a fragmentation or mapping experiment supports a statement about sequence. Where a source says identity was confirmed, we report that a mass was measured, unless we have seen evidence of the second kind.
The rule has consequences we accept. It makes our coverage read as more sceptical than the underlying documents, because the documents claim more than they establish. It occasionally irritates laboratories which have in fact done sequence-level work and have simply not printed it, and the remedy there is a two-line email which we are glad to receive. And it means we cannot describe any research-grade vial in this market as sequence-confirmed, because on the evidence available to us almost none are.
What the rule is not is an accusation. Nothing in this article suggests that vendors are selling material other than what they label, and the Journal has no evidence of that in respect of any company it covers. The claim is narrower and, we think, harder to argue with: the documentation in general circulation does not have the discriminating power that the language on it implies, and the gap between the two is where every avoidable dispute in this market begins.
A tolerance that no plausible measurement could fail is not an acceptance criterion. It is a formality.
On the ±1 dalton conventionm/z — mass-to-charge ratio, the quantity a mass spectrometer actually measures. Monoisotopic mass — mass calculated using the lightest stable isotope of each element. Average mass — mass calculated using standard atomic weights. Nominal mass — the integer sum of integer isotope masses; adequate for small molecules, useless here.
Resolving power — m divided by peak width at half height; the ability to separate nearby masses. Mass accuracy — deviation of a measurement from the true value, in parts per million. Mass defect — the difference between an exact mass and its nominal value, and the property that makes near-isobars separable.
Adduct — an ion formed by association with something other than a proton, commonly sodium or potassium. Charge-state envelope — the family of differently charged ions from one compound. Isobaric — of identical mass at the achieved precision. Isomeric — of identical composition and different structure. b and y ions — the complementary fragment series produced by amide-bond cleavage.
Precision in these terms is not decoration. Several disputes this department has been asked to adjudicate turned out, on inspection, to be disagreements about whether the word mass meant monoisotopic or average.
| Compound | Monoisotopic (Da) | Average (Da) | Difference (Da) | Difference (ppm) |
|---|---|---|---|---|
| BPC-157 | 1418.68 | 1419.53 | 0.85 | 600 |
| Liraglutide | 3748.05 | 3751.20 | 3.15 | 840 |
| Semaglutide | 4111.12 | 4113.58 | 2.46 | 598 |
| Tirzepatide | 4810.47 | 4813.45 | 2.98 | 619 |
| Retatrutide | 4728.42 | 4731.30 | 2.88 | 609 |
| Tesamorelin | 5131.63 | 5135.90 | 4.27 | 831 |
| Values calculated from published molecular formulae for the free-base forms and rounded to two decimal places; salt forms and acylation variants shift these figures. The final column shows why a certificate that does not state its convention cannot be checked: the convention difference alone exceeds any plausible acceptance tolerance. | ||||
The Journal will keep asking suppliers for the underlying laboratory report rather than the certificate, and will keep recording, without editorialising, who supplies one. That register is not a ranking of honesty and we decline to present it as one; readers who think it functions as one anyway should write to standards@compoundjournal.com, where the argument is already under way. It is a measurement of how far back the documentary chain reaches, which is a different property and, in a market assembled from resellers, a useful one.
Selected from correspondence received on this article. Writers are identified by initial, surname and city, verified before printing. Replies are from the desk that filed the piece or from the standards editor. Write to letters@compoundjournal.com.
I would add one omission to your six lines: the date and nature of the last calibration. A parts-per-million figure from an instrument last calibrated a fortnight ago is a different claim from one calibrated that morning with an internal standard.
— K. Oyibo, Benin City
Agreed, and it may be the best suggestion we have received on this subject. It is now a seventh line in the version of the list we send to suppliers, with the note that internal calibration should be stated where it was used.
Your article says a matching mass does not confirm a sequence, which is correct, and then rather implies that vendors are trading on the ambiguity. I run analytical services and I would put it differently: we report what we measured, in the words our clients ask for. If the Journal wants the word confirmed retired, write to the buyers, not to us.
— J. Halloway, Dundee
That is a fair reallocation of the criticism and we accept it. The word is chosen by whoever commissions the report, and laboratories are answering the question they were paid to answer. Our complaint is with the practice, not with the analysts, and the article should have located it more precisely.
On your point about D-amino acids: chiral amino-acid analysis after hydrolysis is not exotic and several contract laboratories offer it. The obstacle is that hydrolysis itself racemises a few per cent of most residues, so the method has a blank problem, and interpreting a low-level D content is genuinely difficult rather than merely expensive.
— Z. Karadzic, Novi Sad
An important qualification and we are glad to have it. The article implied the barrier was commercial when a substantial part of it is methodological. Recorded, and the section has been rewritten accordingly.
Matching a retention time against a standard is evidence of consistency, not proof of identity. Two different species can elute at the same time on one method.
Follow the resin, not the catalogue.
Follow the resin, not the catalogue.
What would be needed to catch each of these, and what it would cost.
The sequence predicts the failure mode. A methionine predicts oxidation; an asparagine followed by a glycine predicts deamidation; a cysteine predicts disulphide scrambling.
Accreditation to the international competence standard covers the scope a laboratory has been assessed for, which is not necessarily the test you commissioned.